What Is the Treatment for Balantidiasis (Balantidium Infection)?

Clinical Overview

Balantidiasis is a human infection caused by Balantidium. Established, evidence-based antibiotic treatment exists for this condition, with specific agent selection and course length depending on the clinical situation.

First-Line Treatment — Partial Overview

First-line management centres on oral antibiotic therapy. More than one treatment option is available; the choice between them, along with the complete dosing framework and duration, is set out in the full structured protocol.

Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.1128/CMR.00021-08

Tetracyclines and metronidazole are treatments of choice for human Balantidium infection.
For metronidazole (Flagyl), the treatment is typically 5 days (adult dosage, 750 mg three times a day; pediatric dosage, 35 to 50 mg kg of body weight−1 day−1 in three doses [maximum dosage, 2 g]), in contrast to tetracycline (adult dosage, 500 mg four times a day; pediatric dosage, 40 mg kg−1 dose−1 in four doses) treatment over 10 days.

View source ↗